How many studies have been conducted on Cd27 Ligand?

BiohacksAI has indexed 48 PubMed studies on Cd27 Ligand. 17% of studies involve human subjects.

What are the main research areas for Cd27 Ligand?

The primary research domains for Cd27 Ligand are 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 48 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cd27 Ligand

A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds to CD27 ANTIGEN. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS where it plays a role in stimulating the proliferation of CD4-POSITIVE T-LYMPHOCYTES and CD8-POSITIVE T-LYMPHOCYTES.

48+ PubMed studies analyzed · Evidence Score: 40.9

Research Domains

Cd27 Ligand has been studied across 14 research domains including 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, 🧠 Memory, 😴 Sleep. The primary research focus is 🔬 Oncology with 85% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd27 Ligand is generated deterministically from 48 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.